BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32362194)

  • 1. Proniosomes as a Carrier System for Transdermal Delivery of Clozapine.
    Tareen FK; Shah KU; Ahmad N; Ur Rehman A; Shah SU; Ullah N
    Drug Dev Ind Pharm; 2020 May; ():1-24. PubMed ID: 32362194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
    Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
    Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of proniosomes containing lornoxicam.
    Madan JR; Ghuge NP; Dua K
    Drug Deliv Transl Res; 2016 Oct; 6(5):511-8. PubMed ID: 27255375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of proniosomes to enhance the transdermal delivery of cilostazole and to ensure the safety of its application.
    Nemr AA; El-Mahrouk GM; Badie HA
    Drug Dev Ind Pharm; 2021 Mar; 47(3):403-415. PubMed ID: 33625936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
    Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
    Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
    Aboelwafa AA; El-Setouhy DA; Elmeshad AN
    AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
    Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
    AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder.
    Rajabalaya R; Leen G; Chellian J; Chakravarthi S; David SR
    Pharmaceutics; 2016 Aug; 8(3):. PubMed ID: 27589789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole:
    Nemr AA; El-Mahrouk GM; Badie HA
    J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of transdermal atorvastatin calcium - Loaded proniosomes: Restoring lipid profile and alleviating hepatotoxicity in poloxamer 407-induced hyperlipidemia.
    Eltellawy YA; El-Kayal M; Abdel-Rahman RF; Salah S; Shaker DS
    Int J Pharm; 2021 Jan; 593():120163. PubMed ID: 33309831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembling Lecithin-Based Mixed Polymeric Micelles for Nose to Brain Delivery of Clozapine: In-vivo Assessment of Drug Efficacy via Radiobiological Evaluation.
    M Elsharkawy F; M Amin M; A Shamsel-Din H; Ibrahim W; Ibrahim AB; Sayed S
    Int J Nanomedicine; 2023; 18():1577-1595. PubMed ID: 37007986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and in vitro permeation studies of proniosomal based transdermal delivery system of Atenolol.
    Ramkanth S; Chetty CM; Sudhakar Y
    Pak J Pharm Sci; 2014 Jan; 27(1):115-20. PubMed ID: 24374439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of optimized zolmitriptan niosomal emulgel.
    Mohamed MI; Abdelbary AA; Kandil SM; Mahmoud TM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1157-1167. PubMed ID: 30919700
    [No Abstract]   [Full Text] [Related]  

  • 15. Formulation and Evaluation of Azithromycin-Loaded Niosomal Gel: Optimization, In Vitro Studies, Rheological Characterization, and Cytotoxicity Study.
    Zaid Alkilani A; Hamed R; Abdo H; Swellmeen L; Basheer HA; Wahdan W; Abu Kwiak AD
    ACS Omega; 2022 Nov; 7(44):39782-39793. PubMed ID: 36385887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication and Characterization of Clozapine Nanoemulsion Sol-Gel for Intranasal Administration.
    Tan MSA; Pandey P; Lohman RJ; Falconer JR; Siskind DJ; Parekh HS
    Mol Pharm; 2022 Nov; 19(11):4055-4066. PubMed ID: 36149013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal Delivery of Telmisartan: Formulation, in vitro, ex vivo, Iontophoretic Permeation Enhancement and Comparative Pharmacokinetic Study in Rats.
    Teaima M; Abdelmonem R; Adel YA; El-Nabarawi MA; El-Nawawy TM
    Drug Des Devel Ther; 2021; 15():4603-4614. PubMed ID: 34785889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proniosomes as a carrier system for transdermal delivery of tenoxicam.
    Ammar HO; Ghorab M; El-Nahhas SA; Higazy IM
    Int J Pharm; 2011 Feb; 405(1-2):142-52. PubMed ID: 21129461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Permeation and Skin Retention of α-Mangostin Proniosome.
    Chin GS; Todo H; Kadhum WR; Hamid MA; Sugibayashi K
    Chem Pharm Bull (Tokyo); 2016; 64(12):1666-1673. PubMed ID: 27904075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and optimization of clotrimazole-loaded proniosomal gel using 3(2) factorial design.
    Thomas L; Viswanad V
    Sci Pharm; 2012; 80(3):731-48. PubMed ID: 23008818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.